Understanding the therapeutic action of antipsychotics

• Verfasst von: Direktor, Merve [VerfasserIn]
• Verfasst von: Gass, Peter [VerfasserIn]
• Verfasst von: Inta, Dragos [VerfasserIn]
• Titel: Understanding the therapeutic action of antipsychotics
• Titelzusatz: from molecular to cellular targets with focus on the islands of Calleja
• Verf.angabe: Merve Direktor, Peter Gass, Dragos Inta
• Jahr: 2024
• Umfang: 5 S.
• Illustrationen: 1 Illustration
• Fussnoten: Online veröffentlicht: 17. April 2024 ; Gesehen am 11.09.2024
• Titel Quelle: Enthalten in: The international journal of neuropsychopharmacology
• Ort Quelle: Oxford : Oxford Univ. Press, 1998
• Jahr Quelle: 2024
• Band/Heft Quelle: 27(2024), 4, Artikel-ID pyae018, Seite [1]-5
• ISSN Quelle: 1469-5111
• DOI: doi:10.1093/ijnp/pyae018
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1902314913

Abstract

The understanding of the pathophysiology of schizophrenia as well as the mechanisms of action of antipsychotic drugs remains a challenge for psychiatry. The demonstration of the therapeutic efficacy of several new atypical drugs targeting multiple different receptors, apart from the classical dopamine D2 receptor as initially postulated unique antipsychotic target, complicated even more conceptualization efforts. Here we discuss results suggesting a main role of the islands of Calleja, still poorly studied GABAergic granule cell clusters in the ventral striatum, as cellular targets of several innovative atypical antipsychotics (clozapine, cariprazine, and xanomeline/emraclidine) effective in treating also negative symptoms of schizophrenia. We will emphasize the potential role of dopamine D3 and M4 muscarinic acetylcholine receptor expressed at the highest level by the islands of Calleja, as well as their involvement in schizophrenia-associated neurocircuitries. Finally, we will discuss the implications of new data showing ongoing adult neurogenesis of the islands of Calleja as a very promising antipsychotic target linking long-life neurodevelopment and dopaminergic dysfunction in the striatum.